CELLCIPHR

Welcome to the Brand page for “CELLCIPHR”, which is offered here for In the statement, column 1, lines 34 thru 39, chemical, biochemical, biological and bacteriological research and analysis; chemistry consultation; consultancy pertaining to pharmacology; design for others in the field of cellular profiling and biomedical assays; is deleted, and in the statement, column 2, lines 1 thru 6, development of new technology for others in the field of biomedical research; diagnostic services in the field of biomedicine; information on the subject of scientific research in the field of biochemistry and biotechnology; is deleted, and in the statement column 2, lines 10 thru 12, medical and scientific research in the field of medical imaging; should be deleted, and in the statement, column 2, lines 14 thru 18, medical and scientific research services in the field of cancer treatment and diagnosis; is deleted, and in the statement column 2, line 18, performance of chemical analyses; is deleted, and in the statement, lines 18 and 19, pharmaceutical product evaluation; should be deleted, and in the statement column 2, lines 22 thru 26, research and development and consultation related thereto in the field of drug discovery and drug development; research in the field of environmental protection; is deleted, and in the statement column 2, lines 28 thru 30, ; technology consultation and research in the field of biomedicine is deleted.;cell cipher;[biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; biochemicals namely, polypeptides for in vitro research use; biochemicals, monoclonal antibodies for in vitro scientific or research use; biological tissue, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; chemical preparations for scientific purposes; chemical test kits for cell assays for laboratory or research use; cytological fixatives; diagnostic preparations for scientific or research use; enzymes for scientific and research purposes; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; reagents for scientific or medical research use; reagents for use in scientific apparatus for chemical or biological analysis; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use];[ chemical, biochemical, biological and bacteriological research and analysis; chemistry consultation; consultancy pertaining to pharmacology; design for others in the field of cellular profiling and biomedical assays; development of new technology for others in the field of biomedical research; diagnostic services in the field of biomedicine; information on the subject of scientific research in the field of biochemistry and biotechnology; ] laboratory research in the field of drug discovery and drug development; measurement evaluations in the fields of cell biology and biomedicine; [ medical and scientific research in the field of medical imaging; ] medical and scientific research in the field of drug discovery and drug development; [ medical and scientific research services in the field of cancer treatment and diagnosis; ] medical research; [ performance of chemical analyses; ] pharmaceutical drug development services; [ pharmaceutical product evaluation; ] pharmaceutical research and development; pharmaceutical research services; [ research and development and consultation related thereto in the field of drug discovery and drug development; research in the field of environmental protection; ] scientific investigations for medical purposes; scientific research [ ; technology consultation and research in the field of biomedicine ];.

Its status is currently believed to be active. Its class is unavailable. “CELLCIPHR” is believed to be currently owned by “CYPROTEX US, LLC”.